Email updates

Keep up to date with the latest news and content from BMC Clinical Pathology and BioMed Central.

Open Access Email this article to a friend

A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer

Takayuki Kobayashi*, Keiichi Iwaya, Tomoyuki Moriya, Tamio Yamasaki, Hitoshi Tsuda, Junji Yamamoto and Osamu Matsubara

BMC Clinical Pathology 2013, 13:5  doi:10.1186/1472-6890-13-5

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Clinical Pathology's emails?